0
American Society for Experimental Neurotherapeutics Abstracts |

The Biology of Neural and Non-Neural Stem Cells FREE

Clive Svendsen, PhD
Arch Neurol. 2003;60(2):297. doi:10.1001/archneur.60.2.297-a.
Text Size: A A A
Published online

What is a stem cell? This is becoming more than a semantic issue in biology these days, as cell therapy approaches clinical trials. It is vital to know exactly what is going on during the growth of "stem cells" in the culture dish, and how pure the population actually is. Which is the best source for generating stem cells — the blastocyst, fetus, or adult? Can they all be grown forever in the tissue culture dish — or do they change with time? Are neural stem cells generated from these tissues really the same? Clearly, the old adage "rubbish in/rubbish out" is well applied to cellular therapy. To avoid catastrophic clinical outcomes, cells must be characterized to the best of our abilities. In this presentation, the biology of "stem cells" generated from different species and different tissues will be presented. One underlying theme will be that, in many cases, stem cells are not actually being grown in culture, but instead, the more restricted "progenitor" cells—with a fixed genetic background related to their origin. Another is that human and rodent progenitor cells are dramatically different in both growth characteristics and phenotypic potential. Finally, stem cells generated from adult human tissues do not overlap seamlessly with those from embryonic sources. These differences seem to be the rule, while the rare exceptions (where cells can return to a primitive state or "transdifferentiate" between germ layers) often grab the spotlight.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Twenty years of experience on stem cell transplantation in iran.
Iran Red Crescent Med J 2013;;15(2):93-100.
Engineering of the embryonic and adult stem cell niches.
Iran Red Crescent Med J 2013;;15(2):83-92.